Seasonal influenza virus vaccine trivalent - Sanofi
Alternative Names: Fluzone; Fluzone Pediatric; Trivalent influenza virus vaccine seasonal - sanofi; VaxigripLatest Information Update: 05 Nov 2023
At a glance
- Originator sanofi pasteur
- Developer Sanofi Pasteur
- Class Influenza virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Influenza virus infections
Most Recent Events
- 01 Aug 2015 Launched for Influenza virus infections (In children, In infants, In adults) in Malaysia, Italy, Indonesia, Hungary, France, Finland, Denmark, Austria, Australia, South Africa, Russia, Israel, Belgium, Spain, Netherlands, China, Chile, Turkey, Singapore, Portugal, Poland, Philippines, New Zealand, Greece (IM) before August 2015
- 01 Jan 2009 Launched for Influenza virus infections in USA (IM)
- 04 Sep 2002 Registered for Influenza virus infections (prevention in adults, children and infants) in USA (IM) - first global approval